PL366996A1 - Sposób i środki do wykrywania chorób indukowanychglutenem - Google Patents

Sposób i środki do wykrywania chorób indukowanychglutenem

Info

Publication number
PL366996A1
PL366996A1 PL02366996A PL36699602A PL366996A1 PL 366996 A1 PL366996 A1 PL 366996A1 PL 02366996 A PL02366996 A PL 02366996A PL 36699602 A PL36699602 A PL 36699602A PL 366996 A1 PL366996 A1 PL 366996A1
Authority
PL
Poland
Prior art keywords
test
induced diseases
autoantigen
liberated
directed
Prior art date
Application number
PL02366996A
Other languages
English (en)
Other versions
PL208039B1 (pl
Inventor
Markku Maki
Ilma Korponay-Szabo
Original Assignee
Markku Maki
Ilma Korponay-Szabo
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=8561063&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PL366996(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Markku Maki, Ilma Korponay-Szabo filed Critical Markku Maki
Publication of PL366996A1 publication Critical patent/PL366996A1/pl
Publication of PL208039B1 publication Critical patent/PL208039B1/pl

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/564—Immunoassay; Biospecific binding assay; Materials therefor for pre-existing immune complex or autoimmune disease, i.e. systemic lupus erythematosus, rheumatoid arthritis, multiple sclerosis, rheumatoid factors or complement components C1-C9
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/90—Enzymes; Proenzymes
    • G01N2333/91—Transferases (2.)
    • G01N2333/91045—Acyltransferases (2.3)
    • G01N2333/91074—Aminoacyltransferases (general) (2.3.2)
    • G01N2333/9108—Aminoacyltransferases (general) (2.3.2) with definite EC number (2.3.2.-)
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/20—Dermatological disorders
    • G01N2800/202—Dermatitis
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/961—Chemistry: molecular biology and microbiology including a step of forming, releasing, or exposing the antigen or forming the hapten-immunogenic carrier complex or the antigen per se

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Hematology (AREA)
  • Engineering & Computer Science (AREA)
  • Urology & Nephrology (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Cell Biology (AREA)
  • Rehabilitation Therapy (AREA)
  • Biotechnology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Rheumatology (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
PL366996A 2001-04-25 2002-04-24 Sposób wykrywania celiakii (CD) lub opryszczkowego zapalenia skóry w próbce krwi pacjenta lub w zhemolizowanej próbce krwi pacjenta i zastosowanie transglutaminazy tkankowej (tTG) uwolnionej z czerwonych krwinek (RBC) z próbki krwi PL208039B1 (pl)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FI20010868A FI20010868A0 (fi) 2001-04-25 2001-04-25 Menetelmä ja välineet gluteenin indusoimien tautien havaitsemiseksi

Publications (2)

Publication Number Publication Date
PL366996A1 true PL366996A1 (pl) 2005-02-07
PL208039B1 PL208039B1 (pl) 2011-03-31

Family

ID=8561063

Family Applications (1)

Application Number Title Priority Date Filing Date
PL366996A PL208039B1 (pl) 2001-04-25 2002-04-24 Sposób wykrywania celiakii (CD) lub opryszczkowego zapalenia skóry w próbce krwi pacjenta lub w zhemolizowanej próbce krwi pacjenta i zastosowanie transglutaminazy tkankowej (tTG) uwolnionej z czerwonych krwinek (RBC) z próbki krwi

Country Status (11)

Country Link
US (1) US7361480B2 (pl)
EP (1) EP1390753B1 (pl)
AT (1) ATE412180T1 (pl)
BR (1) BRPI0209172B8 (pl)
CA (1) CA2445102C (pl)
DE (1) DE60229513D1 (pl)
ES (1) ES2314043T3 (pl)
FI (1) FI20010868A0 (pl)
HU (1) HU229679B1 (pl)
PL (1) PL208039B1 (pl)
WO (1) WO2002086509A1 (pl)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI20010868A0 (fi) * 2001-04-25 2001-04-25 Markku Maeki Menetelmä ja välineet gluteenin indusoimien tautien havaitsemiseksi
GB0117870D0 (en) 2001-07-21 2001-09-12 Univ Nottingham Trent Method of diagnosis and kit of parts therefor
GB0304993D0 (en) * 2003-03-05 2003-04-09 Univ Nottingham Trent Novel screening method
FR2857453B1 (fr) * 2003-07-11 2007-04-20 Covalab Procede de detection serologique de la maladie coeliaque et necessaire de diagnostic associe
MX346450B (es) 2008-11-30 2017-03-17 Immusant Inc * Composiciones y métodos para el tratamiento de la enfermedad celíaca.
CA2923822A1 (en) 2013-09-10 2015-03-19 Immusant, Inc. Dosage of a gluten peptide composition
CA2962933A1 (en) 2014-09-29 2016-04-07 Immusant, Inc. Use of hla genetic status to assess or select treatment of celiac disease
WO2025233646A2 (en) 2024-05-09 2025-11-13 Debreceni Egyetem Detection of celiac disease-specific autoantibodies

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE461616B (sv) * 1987-05-08 1990-03-05 Biocarb Ab Foerfarande och testsats vid diagnos av iga nefropati med bestaemning av fibronektin-iga-komplex
US5200344A (en) * 1990-11-13 1993-04-06 Blaser Martin J Diagnostic testing for campylobacter jejuni or campylobacter coli infections using novel antigens
WO1994020857A1 (en) * 1993-03-11 1994-09-15 The Regents Of The University Of California Assay for humoral immunity to macromolecules
DE19630557C2 (de) * 1996-07-18 1998-07-02 Schuppan Detlef Priv Doz Dr Dr Verfahren zum Nachweis von Antikörpern aus Körperflüssigkeiten durch eine Immunreaktion mit Gewebe-Transglutaminase (tTG) sowie die Verwendung von tTG in Diagnose und Therapie
WO2001001133A2 (en) 1999-06-28 2001-01-04 Immundiagnostik Ag Diagnosis of gluten sensitive enteropathy and other autoimmunopathies
US6703208B1 (en) * 1999-10-20 2004-03-09 Immco Diagnostics Immunological assay for detection of antibodies in celiac disease
FI20010868A0 (fi) * 2001-04-25 2001-04-25 Markku Maeki Menetelmä ja välineet gluteenin indusoimien tautien havaitsemiseksi

Also Published As

Publication number Publication date
PL208039B1 (pl) 2011-03-31
ATE412180T1 (de) 2008-11-15
CA2445102A1 (en) 2002-10-31
HU229679B1 (en) 2014-04-28
WO2002086509A8 (en) 2003-01-16
BR0209172A (pt) 2004-08-03
HUP0400066A3 (en) 2006-01-30
WO2002086509A1 (en) 2002-10-31
CA2445102C (en) 2012-01-03
US20040115750A1 (en) 2004-06-17
ES2314043T3 (es) 2009-03-16
US7361480B2 (en) 2008-04-22
BRPI0209172B1 (pt) 2017-06-06
HUP0400066A2 (hu) 2004-04-28
FI20010868A0 (fi) 2001-04-25
DE60229513D1 (de) 2008-12-04
BRPI0209172B8 (pt) 2021-07-27
EP1390753B1 (en) 2008-10-22
EP1390753A2 (en) 2004-02-25

Similar Documents

Publication Publication Date Title
WO2010027903A8 (en) Lung cancer diagnosis
NO20006681D0 (no) Fremgangsmåte ved tidlig diagnose av karsinomer
NO982265L (no) Diagnostikk for og mediatorer for inflammatoriske forstyrrelser
WO2001012662A3 (en) Membrane associated proteins
DK1421215T3 (da) Fremgangsmåder til evaluering af patologiske tilstande under anvendelse af ekstracellulært RNA
WO2006085984A3 (en) Immune cell biosensors and methods of using same
WO2006076025A3 (en) Immune cell biosensors and methods of using same
AU2002246668A1 (en) Monoclonal antibodies and cell surface antigens for the detection and treatment of small cell lung cancer (sclc)
MX2013008471A (es) Metodos y aparatos para la deteccion de sensibilidad al gluten y su diferenciacion de la enfermedad celiaca.
EP1318399A3 (en) Passive sample detection to initiate timing of an assay
PL358874A1 (pl) Peptydy prezentowane przez komórki
WO2002086509A8 (en) Method and means for detecting gluten-induced diseases
GB0126319D0 (en) Microfluidic serrs detection
DK0991945T4 (da) Fremgangsmåde til identifikation af tumor-antigener med autoantistoffer i serum
WO2006067792A3 (en) Aldolase autoantigens useful in diagnosis and treatment of alzheimer's disease
ATE362526T1 (de) Ceramidasegen
IL175692A0 (en) Method for diagnosing diseases based on levels of anti-glycan antibodies
WO2004039312A3 (en) Optineurin and glaucoma
WO2005040806A3 (en) Use of protein asc as a marker for breast cancer
EP0563244A4 (en) Human phospholipase activating protein and methods for diagnosis of rheumatoid arthritis
WO2005005957A3 (en) Method of detecting cancer using delta-catenin
WO2000078954A3 (en) Human transcriptional regulator proteins
WO2001065262A3 (en) Reagents and methods useful for detecting diseases of the breast
FI990380A7 (fi) Diagnostinen ja seulontamenetelmä
WO2004016065A3 (es) SISTEMA Y PROCEDIMIENTO INMUNOCROMATOGRÁFICO PARA LA INDENTIFICACIÓN SIMULTÁNEA DE ANTICUERPOS FRENTE A AGA Y t-TG, Y SU USO EN EL DIAGNOSTICO DE ENFERMEDAD CELIACA

Legal Events

Date Code Title Description
RECP Rectifications of patent specification